ArticleFrontiers in psychiatry2025
Epidemiological trends in autism and other neurodevelopmental disorders in Kazakhstan (2016-2022): a regional and national perspective.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Building Professional Competence in Autism Care: Results From a Pilot Continuing Education Program in Kazakhstan.Advances in medical education and practice · 2026Article
- Diverging trends in neurodevelopmental disorder diagnoses among children aged below 16 years in Kazakhstan (2014-2024): a national registry study.Frontiers in psychiatry · 2026Article
- Financial challenges and economic impact on families of children with autism spectrum disorder in Kazakhstan.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigates the epidemiological trends of autism spectrum disorder and other neurodevelopmental disorders in Kazakhstan from 2016 to 2022. Methods: Utilizing national healthcare databases, we analyzed the incidence and prevalence of childhood autism, atypical autism, and neurodevelopmental disorders across various regions of Kazakhstan. Results: Our findings reveal a nearly fivefold increase in the diagnosis of childhood autism and a fourfold increase in atypical autism over the seven-year period, with both trends showing statistical significance (p < 0.01). However, no significant trend was observed for broader neurodevelopmental disorders. Regional disparities were evident, with northern regions showing higher rates of ASD diagnoses compared to the southern regions, likely influenced by factors such as healthcare infrastructure, urbanization, and environmental pollution. Astana showed a marked increase in childhood autism prevalence, reaching 263.7 per 100,000 children by 2022. Conclusion: Data highlight an important public health trend in Kazakhstan, where the primary incidence of autism spectrum disorders is on the rise, reflecting improved recognition and diagnostic practices.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.